Table 3.

Multivariable analysis of recurrence and death in 88 women who received chemotherapy and radiation for endometrial cancer

	Risk of recurrence HR (95%CI)*		Risk of death from any cause HR (95%CI)
Health deficits	All women	Subset with ECOG=0	All women	Subset with ECOG=0
Frailty score ≥ 1	2.21 (1.02–4.80)	2.33 (1.04–5.23)	2.34 (1.08–5.03)	2.13 (0.95–4.79)
Age at diagnosis	1.07 (0.99–1.15)	1.06 (0.98–1.16)	1.06 (0.99–1.13)	1.05 (0.97–1.14)
Stage III at diagnosis (vs. all other stages)	0.72 (0.35–1.45)	1.73 (0.34–1.58)	1.02 (0.53–1.99)	1.05 (0.49–2.22)
High grade (vs. grade 1 or 2)	1.88 (0.75–4.74)	1.15 (0.39–3.37)	1.15 (0.53–2.52)	0.97 (0.35–2.70)
Charlson Comorbidity Score ≥ 1	1.06 (0.79–1.42)	0.98 (0.71–1.35)	0.93 (0.69–1.24)	0.93 (0.66–1.32)

^*Hazard ratios (HR) and 95% Confidence Intervals (95%CI) calculated by Cox proportional hazards models.